Abarceo Pharma is a Malmö-based pharmaceutical company developing novel treatments for metabolic diseases including type 2 diabetes and NASH. Founded by researchers Tara Heitner, Claes Wollheim, and Albert Salehi with roots in Lund University research, the company has raised $2.5M and is advancing its drug candidates through pre-clinical and early clinical development.
abarceopharma.comPart of: Skåne Startup map